WhyQuit News Banner: motivation, education and support for cold turkey nicotine cessation. If seeking to quit smoking or stop using e-cigs, bidis, kreteks, hookah, a pipe, cigars, dip, chew, snuff, snus, smokeless, chewing tobacco, or the nicotine gum, lozenge, patch, inhaler or spray, you've come to the right place!
WhyQuit    Law of Addiction    Joel's Library    Freedom    Turkeyville    How to Quit

FOR IMMEDIATE FREE RELEASE
Wednesday, December 16, 2009
PDF version - WhyQuit source link

Contact: John R. Polito
john@whyquit.com
(843) 797-3234




UW-CTRI's Holiday
Health Media Manipulation

The University of Wisconsin's Center for Tobacco Research and Intervention (UW-CTRI) seeks to influence what health journalists and media write and say about the best way to quit smoking this New Years. Will it succeed? Will health news articles tell smokers to spend twice as much on quitting products as last year? Probably.

by John R. Polito, founder of WhyQuit

No nicotine lozenge plus patch New Year's is by far the biggest stop smoking day of the year. Although we expect pharmaceutical industry holiday season creativity in marketing quitting products, this year the University of Wisconsin (UW) is leading the charge. Recipient of millions of dollars in industry funding, it's payback time and media manipulation is the order of the day.

The opening line of a December 14 press release by the UW's Center for Tobacco Research and Intervention (UW-CTRI) reads in part, "smokers trying to quit smoking for the holidays have the best chance for success if they take the nicotine lozenge in combination with either bupropion (a pill) or the nicotine patch."

It's the one line GlaxoSmithKline -- maker of the Commit nicotine lozenge, Nicoderm nicotine patch, and Zyban (bupropion) -- hopes health journalists will seize upon in writing this year's batch of "how to quit smoking" articles.

The press release briefly reviews a UW-CTRI study published in the December 14 issue of Archives of Internal Medicine entitled, "Comparative Effectiveness of 5 Smoking Cessation Pharmacotherapies in Primary Care Clinics." Primary care patients motivated to quit smoking were randomized to one of five quitting product groups while also receiving counseling via a telephone quit line.

The study and press release boast six-month quitting rates of 29.9% in a group that combined use of both the nicotine lozenge and bupropion, 26.9% in a group using both the nicotine lozenge and patch, 19.9% in a group using the nicotine lozenge alone, 17.7% in a group using the patch alone, and 16.8% among those using bupropion alone.

UW-CTRI and GlaxoSmithKline also hope health journalists include the press release zinger that, "the clear message here is that combining the lozenge with the nicotine patch or bupropion gives smokers the best chance to quit." But is it true?

What the UW-CTRI press release does not tell journalists is that neither this study nor its November 2009 clinical companion presents any evidence that any study participant actually broke nicotine's grip upon their mind and life. None. Imagine pronouncing those using multiple avenues to stimulate brain dopamine pathways as having been most successful, when blood, saliva and urine were not examined to determine if stimulation by quitting products actually ended.

What percentage of this study's successful quitters remain hooked on nicotine lozenges today? Doesn't informed consent scream that smokers be told?

What we do know is that a 2003 study found that up to 7% of nicotine gum quitters and 37% of all current gum users remain persistent long-term users for at least 6 months, twice as long as the use period approved by the FDA.

Combination treatment clearly has potential to generate the highest blood serum nicotine levels ever documented in quitting studies. It is highly irresponsible for the University of Wisconsin to strongly advocate combination quitting product use while ignoring evaluation of chronic long-term chemical dependency upon NRT and/or Zyban.

"The clear message here is that combining the lozenge with the nicotine patch or bupropion gives smokers the best chance to quit." Again, is it true? Were any smokers actually able to arrest their chemical dependency upon nicotine? Additionally, is this "clear message" honest when counseling, and not combination therapy, may account for nearly all of the differences seen?

There is consensus among experts that counseling and support are highly effective at helping smokers quit. The focus and intensity of abrupt nicotine cessation (cold turkey) counseling takes aim at getting smokers through the first three days and peak withdrawal. Pharm product counseling's initial objective is successful dependency transfer to a chemical that stimulates brain dopamine pathways.

While successful cold turkey quitting benefits from daily front-end counseling, the closer cessation pharmaceutical products mimic dopamine levels generated by smoking, the longer the user remains cigarette free and able to benefit from ongoing counseling. Obviously, participants have no need for counseling once they relapse to smoking.

This study arranged telephone counseling through the Wisconsin Tobacco Quit Line (WTQL). Although told that the percentage of each quitting product group actually speaking with WTQL counselors was similar (a low of 35% for bupropion group, to a high of 46% for the bupropion plus nicotine lozenge group), the study fails to disclose the total amount of counseling time received by each group, or the total amount of counseling time received by successful quitters within each group.

Instead, readers are told that:

"These results showed that there was not a linear increase in abstinence rates with more minutes of counseling but, instead, users with fewer than 90 minutes of counseling (n=316 had an abstinence rate of 19.6% that was nearly the same as the rate for nonusers of the WTQL (n=801; abstinence rate, 19.5%. In contrast, WTQL users who had more than 90 minutes of counseling had a 6-month abstinence rate of 35.8%."

Shouldn't the "clear message" and big news from this study have been the tremendous value of more than 90 minutes of counseling? The UW-CTRI press release does not once mention that receiving more than 90 minutes of counseling generated a 36% success rate. Why? Is UW-CTRI's primary concern to help GlaxoSmithKline make money or to help smokers quit?

UW-CTRI wants this study to be known as a "real-world" effectiveness evaluation. Frankly, it has very little to do with how smokers quit under "real-world" conditions. How many "real-world" smokers are randomly assigned to one of five quitting groups, given free quitting products, and receive an unsolicited telephone call from a telephone quit line? None. Out here in the real world the vast majority of all successful quitters do not engage in weeks or months of expensive nicotine weaning. They quit cold turkey.

In stark contrast to UW-CTRI's artificial manipulation and control, a true "real-world" study was published in the April 2006 edition of Addictive Behaviors. It was a hands-off study that simply followed smoking patients of Australian primary care physicians and reported on their quitting attempts, the methods they used and their outcomes.

Quitting methods chart prepared by WhyQuit.com using data from a May 2006 study in Addictive Behaviors, Volume 31, at page 764

It found that the success rate for cold turkey quitters was twice as high as the rates for those using the nicotine patch, nicotine gum, nicotine inhaler or Zyban (bupropion). Even more impressive, it found that cold turkey quitters accounted for 1,942 of 2,207 former smokers, a whopping 88% of all success stories.

UW-CTRI refuses to document real patient quitting outcomes of Wisconsin primary care physicians. Why? Because even in Wisconsin cold turkey is king and there would be nothing to sell.

UW-CTRI has already played a key role in redefining "quitting." By its definition we should totally ignore chemical dependency upon nicotine and instead focus only upon success in ending use of just one form of nicotine delivery, the cigarette.

Now it seeks to redefine "real-world" quitting, in asking us to ignore and hide how real-world quitters actually succeed, and how quitting rates among those using quitting products are almost always lower than rates achieved by those quitting without them.

Amazingly, the University of Wisconsin press release does not alert media to the authors' pharmaceutical industry financial ties. It should. The study's financial disclosure states:

"Dr Smith has received research support from Elan Corporation plc. Dr Jorenby has received research support from Pfizer Inc, Sanofi-Synthelabo, and Nabi Biopharmaceuticals and has received consulting fees from Nabi Biopharmaceuticals. Dr Fiore has received honoraria from Pfizer Inc and has served as an investigator on research studies at the University of Wisconsin that were funded by Pfizer Inc, Sanofi- Synthelabo, and Nabi Biopharmaceuticals. In 1998, the University of Wisconsin (UW) appointed Dr Fiore to a named Chair funded by an unrestricted gift to UW from Glaxo Wellcome. Dr Baker has served as an investigator on research projects sponsored by pharmaceutical companies including Sanofi-Synthelabo, Pfizer Inc, and Nabi Biopharmaceuticals."

Will health reporters eventually awaken to researcher study games and industry marketing tactics? Maybe not. It's much easier to simply regurgitate a study press release than to look behind its words to the truth beyond.





I, John R. Polito, am solely responsible for the content of this article.
Any errors brought to my attention will be immediately corrected.
Written December 16, 2009 and last updated December 17, 2009



Sign the petition for honest quit smoking studies





Recent Related Reading








WhyQuit's basic "how to quit smoking" video


Watch 200+ additional free video stop smoking lessons






Read our free quitting e-books

Click to learn more about Joel's free e-book before downloading it              Click to learn more about John's free e-book before downloading it.

Read both and experience the "POWER" of knowledge!






Visit WhyQuit and learn more about smart turkey quitting


Learn More About Smart Turkey Quitting

  • WhyQuit.com's coffin bannerWhyQuit.com - WhyQuit is the Internet's oldest forum devoted to the art, science and psychology of cold turkey quitting, the stop smoking method used by the vast majority of all successful long-term ex-smokers. Left to right, WhyQuit is organized under three headings: (1) Motivation, (2) Education and (3) Support.
  • "Never Take Another Puff" - Imagine a free 149 page stop smoking ebook that's registered more than 4 million downloads and was written by a man who has devoted 40 years, full-time to helping smokers quit. Never Take Another Puff (NTAP) was authored by Joel Spitzer, the Internet's leading authority on how to stop smoking cold turkey. It is an insightful collection of almost 100 articles on every cessation topic imaginable.
  • "Freedom from Nicotine - The Journey Home" - Written by John R. Polito, a former 30-year heavy smoker and WhyQuit's 1999 founder, Freedom from Nicotine (FFN) is a free nicotine dependency recovery book that documents the science underlying nicotine dependency and successful cessation. Visit Turkeyville, Facebook's most popular quit smoking support group!Whether hooked on cigarettes, e-cigarettes (e-cigs), bidis, kreteks, a pipe, hookah or cigars, on dip, chew, snuff or snus, or on the nicotine gum, lozenge, spray, inhaler or patch, FFN provides a comprehensive yet easy to follow road-map to freedom from nicotine.
  • Turkeyville - Visit Turkeyville, Facebook's most popular quit smoking support group. The group's primary focus is the first few days and helping new quitters get started. Yes you can!
  • Joel's Library - Joel's Library is home to Joel Spitzer's "Daily Quitting Lesson Guide." The Guide walks new quitters through the first two weeks of smoking cessation, recommending daily videos to watch and articles to read. Joel's Library is also home to more than 100 original short stop smoking articles, to his free ebook Never Take Another Puff, and to his collection of more than 200 video stop smoking lessons.
  • Nicotine Addiction 101 - WhyQuit's guide to understanding nicotine dependency.
  • Freedom's small link banner Freedom - Looking for a deadly serious and highly focused education oriented support group? Home to Joel Spitzer, Freedom is the Internet's only 100% nicotine-free peer messageboard support forum. Explore Freedom's hundreds of thousands of archived member posts on how to quit smoking.
  • Nicotine Cessation Topic Index - An alphabetical subject matter index to hundreds of nicotine cessation support group discussions, article and videos.
  • 40 Quitting Tips - Key cold turkey nicotine cessation tips on how to stop smoking, vaping, chewing or sucking nicotine into your body and bloodstream.


Knowledge is a Quitting Method!


WhyQuit's small banner image for linking

Article written December 16, 2009 and page last updated December 4, 2012 by John R. Polito